• 1
    Carter MJ, Lobo AJ, Travis SP. IBD Section, British Society of Gastroenterology Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53: V116.
  • 2
    Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990–93. Scand J Gastroenterol 1997; 32: 100512.
  • 3
    Venkataraman S, Mohan V, Ramakrishna BS, et al. Risk of colorectal cancer in ulcerative colitis in India. J Gastroenterol Hepatol 2005; 20: 7059.
  • 4
    Langmead L, Rampton DS. Plain abdominal radiographic features are not reliable markers of disease extent in active ulcerative colitis. Am J Gastroenterol 2002; 97: 3549.
    Direct Link:
  • 5
    Elliott PR, Williams CB, Lennard-Jones JE, et al. Colonoscopic diagnosis of minimal change colitis in patients with a normal sigmoidoscopy and normal air-contrast barium enema. Lancet 1982; 1: 6501.
  • 6
    Koudahl G., Kristensen M. Toxic megacolon in ulcerative colitis. Scand J Gastroenterol 1975; 10: 41721.
  • 7
    Mutinga ML, Odze RD, Wang HH, et al. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis 2004; 10: 2159.
  • 8
    Norland CC, Kirsner JB. Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients. Medicine 1969; 48: 22950.
  • 9
    Stahlberg D, Veress B, Mare K, et al. Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histological assessment and Tc-99 m-HMPAO labeled leukocyte scan. Am J Gastroenterol 1997; 92: 2838.
  • 10
    Stahlberg D, Mare K, Granqvist S, et al. Instant technetium 99 m hexamethyl propylenamine oxime-labeled leukocyte scan compared with colonoscopy in early assessment of disease extent and activity in acute colitis. Dis Colon Rectum 1996; 39: 114652.
  • 11
    Almer S, Franzen L, Peters AM, et al. Do technetium-99 m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 1992; 27: 10318.
  • 12
    Middleton SJ, Li D, Wharton S, et al. Validation of 99Tcm-HMPAO leucocyte scintigraphy in ulcerative colitis by comparison with histology. Br J Radiol 1995; 68: 10616.
  • 13
    Vilien M, Nielsen SL, Jorgensen M, et al. Leucocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1992; 27: 5826.
  • 14
    Guimbaud R, Beades E, Chauvelot-Moachon L, et al. Technetium Tc 99 m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8. Gastrointest Endosc 1998; 48: 4916.
  • 15
    Spinelli F, Milella M, Sara R, et al. The 99 mTc-HMPAO leukocyte scan: an alternative to radiology and endoscopy in evaluating the extent and the activity of inflammatory bowel disease. J Nucl Biol Med 1991; 35: 827.
  • 16
    Madsen SM, Thomsen HS, Munkholm P, et al. Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99 mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery. Scand J Gastroenterol 2002; 37: 30716.
  • 17
    Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986; 90: 11218.
  • 18
    Weldon MJ, Lowe C, Joseph AE, et al. Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy. Aliment Pharmacol Ther 1996; 10: 12332.
  • 19
    Fleiss JL, Cohen, J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 1973; 33: 6139
  • 20
    Hutchinson TP. Focus on psychometrics. Kappa muddles together two sources of disagreement: tetrachoric correlation is preferable. Res Nurs Health 1993; 16: 3136.
  • 21
    Feinstein AR. Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990; 43: 5439.
  • 22
    Hutchinson TP. Agreement between experts: an answer, but is it the answer for you? J Clin Neurosci 2003; 10: 2135.
  • 23
    Moum B, Ekbom A, Vatn MH, Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999; 94: 15649.
    Direct Link:
  • 24
    Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis 2006; 12: 53742.
  • 25
    Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut 1991; 32: 1748.
  • 26
    Solem CA, Loftus Jr EV, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 70712.
  • 27
    Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006; 101: 127482.
    Direct Link: